Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2013

01.08.2013 | Commentary

A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment

verfasst von: Pablo Moura Santos, Lúcia Noblat, Álvaro A. Cruz

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Asthma is a chronic inflammatory disorder of the airways that is characterized by recurrent symptoms associated with airflow limitation and by bronchial hyper-responsiveness. Free asthma treatment has been guaranteed in Brazil since 2003, notably after the Brazilian government decided to support drugs for the most serious forms of the disease. The asthma treatment access policy in Brazil offers a new opportunity for pharmacists to work closely with patients, and for caregivers and health care teams to promote educational activities and patient counselling about asthma. Pharmacists have an important role in the management of drug therapy within the health care team. Pharmacists should be prepared to engage with the latest concept of health care delivery proposed for Brazilian Unified Health System. These are centred on forming health care networks and strengthening multidisciplinary teams to integrate all professionals who are in charge of patient care.
Literatur
1.
Zurück zum Zitat World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007.
2.
Zurück zum Zitat Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.PubMedCrossRef Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.PubMedCrossRef
3.
Zurück zum Zitat Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed
4.
Zurück zum Zitat Ministério da Saúde (Brasil). Portaria no. 1.146 de 1 de junho de 2012. Altera e acresce dispositivos à portaria n 971/GM/MS, de 17 de maio de 2012, para ampliar a cobertura da gratuidade no âmbito do Programa Farmácia Popular do Brasil. Diário Oficial da União 2012; 1:107. [Brazilian Ministry of Health. Decree no. 1146 of 1 June 2012. Amends and adds provisions to the Decree no. 971/GM/MS of May 17, 2012, to expand the coverage of gratuity under the Popular Pharmacy Program in Brazil. Official Gazette 2012; 1:107]. Ministério da Saúde (Brasil). Portaria no. 1.146 de 1 de junho de 2012. Altera e acresce dispositivos à portaria n 971/GM/MS, de 17 de maio de 2012, para ampliar a cobertura da gratuidade no âmbito do Programa Farmácia Popular do Brasil. Diário Oficial da União 2012; 1:107. [Brazilian Ministry of Health. Decree no. 1146 of 1 June 2012. Amends and adds provisions to the Decree no. 971/GM/MS of May 17, 2012, to expand the coverage of gratuity under the Popular Pharmacy Program in Brazil. Official Gazette 2012; 1:107].
6.
Zurück zum Zitat Ministério da Saúde (Brasil). Portaria no. 1.318 de 23 de julho de 2002. Diário Oficial da União. 2002;1:68. [Ministry of Health. Decree no. 1318 of 23 July 2002. Official Gazette 2002; 1:68]. Ministério da Saúde (Brasil). Portaria no. 1.318 de 23 de julho de 2002. Diário Oficial da União. 2002;1:68. [Ministry of Health. Decree no. 1318 of 23 July 2002. Official Gazette 2002; 1:68].
7.
Zurück zum Zitat Ministério da Saúde (Brasil). Portaria no. 2.577 de 27 de outubro de 2006. Diário Oficial da União. 2006;1:44. [Ministry of Health. Decree no. 2577, 27 October 2006. Official Gazette 2006, 1:44]. Ministério da Saúde (Brasil). Portaria no. 2.577 de 27 de outubro de 2006. Diário Oficial da União. 2006;1:44. [Ministry of Health. Decree no. 2577, 27 October 2006. Official Gazette 2006, 1:44].
8.
Zurück zum Zitat Ministério da Saúde (Brasil). Portaria no. 2.084 de 26 de outubro de 2005. Diário Oficial da União. 2006;1:44. [Ministry of Health Decree no. 2084 of 26 October 2005. Official Gazette 2006, 1:44]. Ministério da Saúde (Brasil). Portaria no. 2.084 de 26 de outubro de 2005. Diário Oficial da União. 2006;1:44. [Ministry of Health Decree no. 2084 of 26 October 2005. Official Gazette 2006, 1:44].
9.
Zurück zum Zitat Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o manejo da asma. J Bras Pneumol. 2012; 38 Suppl 1: S1-S46. [Guidelines of the Brazilian Thoracic Association for the Treatment of Asthma]. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o manejo da asma. J Bras Pneumol. 2012; 38 Suppl 1: S1-S46. [Guidelines of the Brazilian Thoracic Association for the Treatment of Asthma].
10.
Zurück zum Zitat Cerci Neto A, Ferreira Filho OF, Bueno T, et al. Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil. J Bras Pneumol. 2008;34(9):639–45.PubMedCrossRef Cerci Neto A, Ferreira Filho OF, Bueno T, et al. Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil. J Bras Pneumol. 2008;34(9):639–45.PubMedCrossRef
11.
Zurück zum Zitat Franco R, Nascimento HF, Cruz AA, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64:478–83.PubMedCrossRef Franco R, Nascimento HF, Cruz AA, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64:478–83.PubMedCrossRef
12.
Zurück zum Zitat Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 1, Art. No. CD000336. doi: 10.1002/14651858.CD000336.pub4. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 1, Art. No. CD000336. doi: 10.​1002/​14651858.​CD000336.​pub4.
13.
Zurück zum Zitat Santos DB, Cruz AA, Simões SM, et al. Pattern of asthma medication use among children from a large urban center in Brazil. Eur J Clin Pharmacol. 2012;68(1):73–82.PubMedCrossRef Santos DB, Cruz AA, Simões SM, et al. Pattern of asthma medication use among children from a large urban center in Brazil. Eur J Clin Pharmacol. 2012;68(1):73–82.PubMedCrossRef
14.
Zurück zum Zitat Santos DO, Martins MC, Cipriano SL, et al. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol. 2010;36(1):14–22.CrossRef Santos DO, Martins MC, Cipriano SL, et al. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol. 2010;36(1):14–22.CrossRef
15.
Zurück zum Zitat Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician’s Guide. 2nd ed. The McGraw-Hill, c2004. ISBN 0-07-136259-2. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician’s Guide. 2nd ed. The McGraw-Hill, c2004. ISBN 0-07-136259-2.
16.
Zurück zum Zitat Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902.PubMedCrossRef Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902.PubMedCrossRef
Metadaten
Titel
A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment
verfasst von
Pablo Moura Santos
Lúcia Noblat
Álvaro A. Cruz
Publikationsdatum
01.08.2013
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2013
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9807-7

Weitere Artikel der Ausgabe 4/2013

International Journal of Clinical Pharmacy 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.